The DOI matches its Crossref record.
Orthotopic liver transplantation using low-dose tacrolimus and sirolimus
Abstract
Although sirolimus (SRL) binds the immunophilin FK506-binding protein-12 (FKBP-12) with greater avidity than tacrolimus (TAC), animal studies have shown that SRL and TAC act synergistically to prevent rejection. Dose-related toxicity is more often the cause of TAC discontinuation than rejection. We hypothesized that SRL would allow for a substantial reduction in the concomitant dose of TAC after liver transplantation to levels less than the threshold for toxicity. A series of 56 liver transplant recipients were administered a combination of SRL and TAC (target trough levels, 7 and 5 ng/mL, respectively). Planned weaning of steroids commenced after 3 months. Pharmacokinetic (PK) studies were undertaken. Patient and graft survival were 52 patients (93%) and 51 grafts (91%), with a follow-up of 23 months (range, 6 to 35 months). One episode (1.8%) of hepatic artery thrombosis was seen. The rate of acute cellular rejection was 14%. No extra treatment was administered in 3 of 8 patients, and the other 5 episodes responded to a single course of steroids. Cytomegalovirus infection occurred in 4 patients (7%). Renal function, glucose control, and lipid metabolism are near normal in 47 patients (84%) without additional medication. Steroid elimination is completed in 51 patients (91%). Bioavailability of SRL and TAC varied between transplant recipients, but trough levels strongly correlated with the area under the curve (r2 = 0.82 and r2 = 0.84, respectively). Simultaneous administration did not affect the PK profile of the drugs at this dose. The ratio of trough level to daily dose correlated between SRL and TAC. The synergistic effect seen in animal models also occurs in clinical liver transplant recipients on SRL-TAC combination immunosuppression. A low-dose combination of SRL and TAC should be compared with conventional immunosuppression in a multicenter, randomized, controlled trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Taylor, A. L., Watson, C. J. E., & Bradley, J. A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.012 · Cited by 445
Laryea, M., Watt, K. D., Molinari, M., Walsh, M. J., McAlister, V. C., Marotta, P. J., Nashan, B., & Peltekian, K. M. (2007) · Liver Transplantation · doi:10.1002/lt.21126 · Cited by 314
Self-citationFlechner, S. M., Kobashigawa, J., & Klintmalm, G. (2008) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00739.x · Cited by 310
Neurologic complications after solid organ transplantation.
Marco, S., Cecilia, F., & Patrizia, B. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00780.x · Cited by 191
Metadata
- Authors
- McAlister, V. C., Peltekian, K. M., Malatjalian, D. A., Colohan, S., MacDonald, S., Bitter-Suermann, H., & MacDonald, A. S.
- Venue
- Liver Transplantation
- Published
- 2001-08
- Volume
- 7
- Issue
- 8
- Pages
- 701-708
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2002473063
- Cited by
- 167
- References
- 0
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. https://app.cochat.ai/papers/10.1053/jlts.2001.26510
- The paper
- McAlister, V. C., Peltekian, K. M., Malatjalian, D. A., Colohan, S., MacDonald, S., Bitter-Suermann, H., & MacDonald, A. S. (2001). Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. Liver Transplantation. https://doi.org/10.1053/jlts.2001.26510
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.